{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:02:08Z","timestamp":1791896528680,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jaad.2006.04.084","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T07:30:00Z","timestamp":1162971000000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Systematic review of rosacea treatments"],"prefix":"10.1016","volume":"56","author":[{"given":"Esther J.","family":"van Zuuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Gover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.04.084_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003262.pub3","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2005","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jaad.2006.04.084_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea, I: etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib4","first-page":"907","article-title":"Standard grading system for rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib5","first-page":"20","article-title":"Frequency, severity and treatment of ocular rosacea during cutaneous rosacea","volume":"130","author":"Michel","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib6","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib7","first-page":"144","article-title":"Rosacea: classification and treatment","volume":"90","author":"Jansen","year":"1997","journal-title":"J\u00a0R\u00a0Soc Med"},{"key":"10.1016\/j.jaad.2006.04.084_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000077298","article-title":"A personal critique on the state of knowledge of rosacea","volume":"208","author":"Kligman","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.04.084_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3810\/pgm.2002.12.1366","article-title":"Unraveling the mystery of rosacea: keys to getting the red out","volume":"112","author":"Landow","year":"2002","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaad.2006.04.084_bib10","first-page":"251","article-title":"Rosacea: where are we now?","volume":"3","author":"Bikowski","year":"2004","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib11","doi-asserted-by":"crossref","first-page":"P174","DOI":"10.1016\/j.jaad.2003.11.022","article-title":"The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: evaluation of a single-site comparative trial subset","volume":"50","author":"Del Rosso","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A comparison of the efficacy of\u00a0topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib13","first-page":"129","article-title":"Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea","volume":"120","author":"Espagne","year":"1993","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib14","first-page":"9","article-title":"The subtypes of rosacea: implications for treatment","volume":"73","author":"Odom","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000079884","article-title":"The histopathology of rosacea: 'where's the beef?'","volume":"209","author":"Powell","year":"2004","journal-title":"Dermatology"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.04.084_bib16","doi-asserted-by":"crossref","first-page":"56s","DOI":"10.1111\/1523-1747.ep12468949","article-title":"Rosacea","volume":"88","author":"Rebora","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib17","first-page":"15","article-title":"Mechanism-based selection of pharmacologic agents for rosacea","volume":"73","author":"Shalita","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib18","first-page":"177","article-title":"A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea","volume":"56","author":"Signore","year":"1995","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib20","first-page":"19","article-title":"The role of topical metronidazole in the treatment of rosacea","volume":"73","author":"Wolf","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and\u00a0topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","article-title":"A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea","volume":"109","author":"Nielsen","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea, II: therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/sim.1206","article-title":"Meta-analysis combining parallel and cross-over clinical trials, II: binary outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jaad.2006.04.084_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0161-6420(96)30412-0","article-title":"The efficacy of topical metronidazole in the treatment of ocular rosacea","volume":"103","author":"Barnhorst","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2006.04.084_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bjo.66.6.386","article-title":"Oxytetracycline in the treatment of ocular rosacea: a double-blind trial","volume":"66","author":"Bartholomew","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2006.04.084_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03259203","article-title":"A double-blind randomized study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea, a placebo controlled study","volume":"2","author":"Bitar","year":"1990","journal-title":"Drug Invest"},{"key":"10.1016\/j.jaad.2006.04.084_bib30","first-page":"187","article-title":"Metronidazole (Elyzol) 1%\u00a0cream vs. placebo cream in the treatment of rosacea","volume":"26","author":"Bjerke","year":"1989","journal-title":"Clin Trials J"},{"key":"10.1016\/j.jaad.2006.04.084_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1987.01660290077020","article-title":"Topical metronidazole therapy for rosacea","volume":"123","author":"Bleicher","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib33","first-page":"44","article-title":"A\u00a0double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea","volume":"61","author":"Breneman","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of patients with moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"Int J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.04.084_bib35","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3109\/09546639309082150","article-title":"Topical azelaic acid in the treatment of rosacea","volume":"4","author":"Carmichael","year":"1993","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2006.04.084_bib36","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib37","first-page":"687","article-title":"Rilmenidine in rosacea: a double-blind study versus placebo","volume":"124","author":"Grosshans","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","article-title":"The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial","volume":"39","author":"Jorizzo","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea: a randomized double-blind placebo-controlled study","volume":"205","author":"Ko\u00e7ak","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.04.084_bib40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","article-title":"Comparative effectiveness of tetracycline and\u00a0ampicillin in rosacea: a controlled trial","volume":"2","author":"Marks","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.04.084_bib41","first-page":"185","article-title":"Topical treatment of acne rosacea with benzoyl peroxide acetone gel","volume":"32","author":"Montes","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","article-title":"Treatment of rosacea with 1% metronidazole cream: a double-blind study","volume":"108","author":"Nielsen","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1346-8138.2004.tb00566.x","article-title":"Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea","volume":"31","author":"\u00d6zturkcan","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib44","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","article-title":"Treatment of rosacea by metronidazole","volume":"1","author":"Pye","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.04.084_bib45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","article-title":"A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea","volume":"102","author":"Saihan","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09546639709160276","article-title":"The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study","volume":"8","author":"Sauder","year":"1997","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2006.04.084_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","article-title":"A clinical trial of tetracycline in rosacea","volume":"78","author":"Sneddon","year":"1966","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib48","first-page":"529","article-title":"Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea","volume":"6","author":"Tan","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2006.04.084_bib49","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of\u00a0azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib50","first-page":"209","article-title":"Topical metronidazole in the treatment of rosacea","volume":"38","author":"Veien","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib51","first-page":"11","article-title":"Photographic review of results from a clinical study comparing benzoyl peroxide 5%\/clindamycin 1% topical gel with vehicle in the treatment of rosacea","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.04.084_bib52","first-page":"1490","article-title":"Acne rosacea: efficacy of a metronidazole cream","volume":"12","author":"Aitken","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2006.04.084_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1346-8138.1992.tb03227.x","article-title":"Oral spironolactone therapy in male patients with rosacea","volume":"19","author":"Aizawa","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib54","first-page":"346","article-title":"Evaluation of topical metronidazole gel in acne rosacea","volume":"21","author":"Aronson","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jaad.2006.04.084_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.1982.tb00290.x","article-title":"Alcohol-induced rosacea flushing blocked by naloxone","volume":"107","author":"Bernstein","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib56","first-page":"2295","article-title":"Rosacea: clinical features and treatment","volume":"109","author":"Bjerke","year":"1989","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.jaad.2006.04.084_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/0001555564358359","article-title":"Topical treatment with sulfur 10 per cent for rosacea","volume":"64","author":"Blom","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib58","first-page":"185","article-title":"Treatment of Helicobacter pylori infection in the management rosacea","volume":"6","author":"Bukvi\u0107-Mokos","year":"1998","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2006.04.084_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmj.1.6053.105","article-title":"Clonidine and facial flushing in rosacea","volume":"1","author":"Cunliffe","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2006.04.084_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","article-title":"Once-daily topical metronidazole cream formulations in the treatment of\u00a0the papules and pustules of rosacea","volume":"45","author":"Dahl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib61","first-page":"176","article-title":"Double blind, parallel study of efficacy and safety of clindamycine lotion in the treatment of rosacea","volume":"41","author":"De Witt","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.04.084_bib62","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0926-9959(98)95615-X","article-title":"Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea. P373","volume":"11","author":"Dreno","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib63","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","article-title":"Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea","volume":"134","author":"Erdogan","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.140.4.489","article-title":"Oral use of azithromycin for the treatment of acne rosacea","volume":"140","author":"Fernandez-Obregon","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib65","first-page":"506","article-title":"Dimensions of the sample and power of the clinical experimentation in a study of antibiotic therapy","volume":"108","author":"Frigerio","year":"1969","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.jaad.2006.04.084_bib66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2006.04.084_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000257895","article-title":"Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to the rebound phenomenon","volume":"152","author":"Go","year":"1976","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.04.084_bib68","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.1989.03420140014003","article-title":"New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects","volume":"261","author":"Goldsmith","year":"1989","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.04.084_bib69","first-page":"S145","article-title":"Metronidazole 0.75% gel and lotion are both effective in the treatment of rosacea","volume":"12","author":"Guillet","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2004.01472.x","article-title":"Continuous 'microdose' isotretinoin in adult recalcitrant rosacea","volume":"29","author":"Hofer","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib71","unstructured":"Irvine C, Kumar P, Marks R. Acne and related disorders\u2013proceedings of an international symposium. London: Marks R, Plewig G, and Dunitz Ltd; 1988. pp. 301-5."},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.04.084_bib72","first-page":"S143","article-title":"Dark sulfonated shale oil versus placebo in the systemic treatment of rosacea","volume":"12","author":"Koch","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib73","first-page":"183","article-title":"The comparative efficacy of sodium sulfacetamide 10%\/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (metrogel) in the treatment of rosacea","volume":"3","author":"Lebwohl","year":"1995","journal-title":"J Geriatr Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib74","first-page":"61","article-title":"Ivermectin cream in rosacea: comparison with metronidazole gel","volume":"151","author":"Loo","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib75","first-page":"148","article-title":"Treatment of rosacea with tetracycline and metronidazole\u2013a comparative study","volume":"35","author":"Nasir","year":"1985","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jaad.2006.04.084_bib76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","article-title":"The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream","volume":"109","author":"Nielsen","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2003.10.192","article-title":"Combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"50","author":"Sanchez","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF03259568","article-title":"Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea","volume":"3","author":"Schachter","year":"1991","journal-title":"Drug Invest"},{"key":"10.1016\/j.jaad.2006.04.084_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjo.79.1.42","article-title":"Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea","volume":"79","author":"Seal","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2006.04.084_bib80","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-4362.1997.00301.x","article-title":"Clarithromycin versus doxycycline in the treatment of rosacea","volume":"36","author":"Torresani","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.1997.tb00469.x","article-title":"Treatment of rosacea with ketoconazole","volume":"8","author":"Uta\u015f","year":"1997","journal-title":"J\u00a0Eur\u00a0Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib82","first-page":"729","article-title":"Treatment of rosacea: clonidine (0.075 mg per day) versus placebo (initial results)","volume":"124","author":"Van Landuyt","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.04.084_bib83","first-page":"381","article-title":"Metronidazole cream for the local treatment of rosacea","volume":"150","author":"Veien","year":"1988","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.jaad.2006.04.084_bib84","first-page":"94","article-title":"Treatment of rosacea fulminans with isotretinoin and topical aclometasone dipropionate","volume":"6","author":"Veraldi","year":"1996","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib85","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","article-title":"Topical metronidazole in the treatment of rosacea","volume":"2","author":"Monk","year":"1991","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2006.04.084_bib87","first-page":"472","article-title":"Comparative study of topical erythromycin and topical metronidazole in the treatment of rosacea","volume":"9","author":"Verea Hernando","year":"1992","journal-title":"Farm Clin"},{"key":"10.1016\/j.jaad.2006.04.084_bib88","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2006.04.084_bib89","first-page":"101","article-title":"De behandeling of rosacea","volume":"32","author":"de Groot","year":"1998","journal-title":"Gebu"},{"key":"10.1016\/j.jaad.2006.04.084_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea: new and emerging therapies","volume":"18","author":"Thiboutot","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2006.04.084_bib91","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-4362.1983.tb02157.x","article-title":"Rosacea","volume":"22","author":"Wilkin","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea: pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.04.084_bib93","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206022626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206022626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:04:58Z","timestamp":1759269898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206022626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0190962206022626"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.04.084","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of rosacea treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}